128 related articles for article (PubMed ID: 8615671)
1. Transcription factor decoy approach to decipher the role of NF-kappa B in oncogenesis.
Sharma HW; Perez JR; Higgins-Sochaski K; Hsiao R; Narayanan R
Anticancer Res; 1996; 16(1):61-9. PubMed ID: 8615671
[TBL] [Abstract][Full Text] [Related]
2. The NF-kappaB transcription factor in oncogenesis.
Sharma HW; Narayanan R
Anticancer Res; 1996; 16(2):589-96. PubMed ID: 8687102
[TBL] [Abstract][Full Text] [Related]
3. A DNA motif present in alpha V integrin promoter exhibits dual binding preference to distinct transcription factors.
Sharma HW; Higgins-Sochaski K; Perez JR; Narayanan R
Anticancer Res; 1995; 15(5B):1857-67. PubMed ID: 8572570
[TBL] [Abstract][Full Text] [Related]
4. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
5. Antisense therapy of cancer.
Narayanan R
In Vivo; 1994; 8(5):787-93. PubMed ID: 7727726
[TBL] [Abstract][Full Text] [Related]
6. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
Wang W; Abbruzzese JL; Evans DB; Larry L; Cleary KR; Chiao PJ
Clin Cancer Res; 1999 Jan; 5(1):119-27. PubMed ID: 9918209
[TBL] [Abstract][Full Text] [Related]
7. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model.
Kawamura I; Morishita R; Tomita N; Lacey E; Aketa M; Tsujimoto S; Manda T; Tomoi M; Kida I; Higaki J; Kaneda Y; Shimomura K; Ogihara T
Gene Ther; 1999 Jan; 6(1):91-7. PubMed ID: 10341880
[TBL] [Abstract][Full Text] [Related]
9. Induction of nuclear factor-kappa B during primary B cell differentiation.
Kistler B; Rolink A; Marienfeld R; Neumann M; Wirth T
J Immunol; 1998 Mar; 160(5):2308-17. PubMed ID: 9498771
[TBL] [Abstract][Full Text] [Related]
10. Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-kappaB have a malignantly transformed phenotype.
Gapuzan ME; Yufit PV; Gilmore TD
Oncogene; 2002 Apr; 21(16):2484-92. PubMed ID: 11971183
[TBL] [Abstract][Full Text] [Related]
11. relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells.
Ricca A; Biroccio A; Trisciuoglio D; Cippitelli M; Zupi G; Del Bufalo D
Br J Cancer; 2001 Dec; 85(12):1914-21. PubMed ID: 11747334
[TBL] [Abstract][Full Text] [Related]
12. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
Kim DW; Gazourian L; Quadri SA; Romieu-Mourez R; Sherr DH; Sonenshein GE
Oncogene; 2000 Nov; 19(48):5498-506. PubMed ID: 11114727
[TBL] [Abstract][Full Text] [Related]
13. Distinct nuclear factor-kappaB/Rel proteins have opposing modulatory effects in glutamate-induced cell death in HT22 cells.
Ishige K; Tanaka M; Arakawa M; Saito H; Ito Y
Neurochem Int; 2005 Dec; 47(8):545-55. PubMed ID: 16183169
[TBL] [Abstract][Full Text] [Related]
14. NF-kappa B subunit-specific regulation of the interleukin-8 promoter.
Kunsch C; Rosen CA
Mol Cell Biol; 1993 Oct; 13(10):6137-46. PubMed ID: 8413215
[TBL] [Abstract][Full Text] [Related]
15. Substance P activates coincident NF-AT- and NF-kappa B-dependent adhesion molecule gene expression in microvascular endothelial cells through intracellular calcium mobilization.
Quinlan KL; Naik SM; Cannon G; Armstrong CA; Bunnett NW; Ansel JC; Caughman SW
J Immunol; 1999 Nov; 163(10):5656-65. PubMed ID: 10553096
[TBL] [Abstract][Full Text] [Related]
16. Nf-kappa B: an important transcription factor in photobiology.
Legrand-Poels S; Schoonbroodt S; Matroule JY; Piette J
J Photochem Photobiol B; 1998 Aug; 45(1):1-8. PubMed ID: 9819895
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines.
Bentires-Alj M; Dejardin E; Viatour P; Van Lint C; Froesch B; Reed JC; Merville MP; Bours V
Oncogene; 2001 May; 20(22):2805-13. PubMed ID: 11420692
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells.
Ammon C; Mondal K; Andreesen R; Krause SW
Biochem Biophys Res Commun; 2000 Feb; 268(1):99-105. PubMed ID: 10652220
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
Ogretmen B; Safa AR
Biochemistry; 1999 Feb; 38(7):2189-99. PubMed ID: 10026303
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
